TY - JOUR T1 - Resolution of Refractory Symptoms of Secondary Erythermalgia With Intermittent Epidural Bupivacaine JF - Regional Anesthesia & Pain Medicine JO - Reg Anesth Pain Med SP - 488 LP - 490 DO - 10.1053/rapm.2001.25930 VL - 26 IS - 5 AU - Lori J. Stricker AU - Carmen R. Green Y1 - 2001/09/01 UR - http://rapm.bmj.com/content/26/5/488.abstract N2 - Background and Objectives Erythermalgia is a rare disorder characterized by erythema, edema, elevated skin temperature, and burning pain of the hands and/or feet. The etiology of primary erythermalgia is idiopathic while secondary erythermalgia is associated with autoimmune and rheumatologic factors. Symptoms are typically refractory to medical management. We report the use of epidural bupivacaine as a treatment option for secondary erythermalgia.Case Report A 28-year-old woman presented with secondary erythromelalgia that was characterized by severe pain, swelling, and erythema. Medical management failed and a lumbar epidural dosed with bupivacaine was used. This resulted in complete resolution of the patient's symptoms.Conclusion Intermittent epidural bupivacaine may provide treatment of the refractory symptoms of secondary erythermalgia. ER -